Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
6
×
immunotherapy
6
×
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
6
×
national
bristol-myers squibb
clinical trials
glaxosmithkline
novartis
scott gottlieb
abbvie
acquisition
aimmune therapeutics
akcea therapeutics
amgen
cancer immunotherapy
What
roundup
annual
bio
cancer
celgene
days
time
abbvie’s
according
agency
ahead
aimmune
airport
akcea
allergy
apocalypse
approval
approved
ash
awarded
barcelona
beds
biofourmis
biopharma
biotech
bucks
car
cases
celebrate
centers
chance
cigarettes
clinical
colleagues
conference
control
corner
day
deaths
december's
Language
unset
Current search:
immunotherapy
×
fda
×
" wisconsin top stories "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More